Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial. uri icon

authors

  • Colombo, Nicoletta
  • Gourley, Charlie
  • Banerjee, Susana
  • Oza, Amit
  • González-Martín, Antonio
  • Aghajanian, Carol
  • Bradley, William H
  • Kim, Jae-Weon
  • Mathews, Cara
  • Liu, Joyce
  • Lowe, Elizabeth S
  • Moore, Kathleen
  • Bloomfield, Ralph
  • DiSilvestro, Paul
  • Scambia, Giovanni
  • Oaknin, Ana
  • Friedlander, Michael
  • Lisyanskaya, Alla
  • Floquet, Anne
  • Leary, Alexandra
  • Sonke, Gabe S

publication date

  • January 1, 2021